The Role of Inositols in Endocrine and Neuroendocrine Tumors

Marilda Mormando1, Giulia Puliani1, Marta Bianchini1

  • 1Oncological Endocrinology Unit, IRCCS Regina Elena National Cancer Institute, Via Elio Chianesi 53, 00144 Rome, Italy.

Biomolecules
|August 29, 2024
PubMed

Insights

Inositols show promise in cancer treatment by regulating key cellular pathways. This review explores their potential as an adjuvant therapy for endocrine and neuroendocrine tumors.

Area of Science:

  • Oncology
  • Molecular Biology
  • Endocrinology

Background:

  • Inositols are involved in cancer prevention and treatment across various neoplasms.
  • Their mechanisms include regulating survival, proliferation, immunity, and oxidative stress pathways.
  • Dysregulation of these pathways is observed in endocrine and neuroendocrine tumors.

Purpose of the Study:

  • To review the molecular mechanisms of inositols in endocrine and neuroendocrine tumors.
  • To evaluate the potential of inositol supplementation as an adjuvant therapy.

Main Methods:

  • Literature review of molecular mechanisms.
  • Analysis of inositol's role in endocrine and neuroendocrine tumor pathways.

Main Results:

  • Inositols modulate pathways crucial to cancer development and progression.
  • Evidence suggests a potential role in endocrine and neuroendocrine tumor contexts.

Conclusions:

  • Inositols possess molecular mechanisms relevant to endocrine and neuroendocrine tumors.
  • Further research is warranted to establish inositol supplementation as an effective adjuvant therapy.

Related Concept Videos

Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
2.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K